Latest News

IDT Corporation recently reported past second-quarter fiscal 2026 results showing higher sales and net income year-over-year, alongside improved earnings per share from continuing operations. The board also raised the annual dividend from US$0.24 to US$0.28 per share, signaling confidence in the company’s cash generation and capital return plans. With this dividend increase as a starting point, we’ll now examine how these developments could influence IDT’s broader investment narrative. AI is...

Huabao International Holdings (SEHK:336) has just released its FY 2025 first half scorecard, with revenue of C¥1,621.2 million and basic EPS of C¥0.0366, set against trailing twelve month figures that still reflect net losses. Over recent periods, revenue has moved between C¥1,582.3 million and C¥1,790.98 million per half year while basic EPS has ranged from C¥0.0092 to a loss of C¥0.1285. This gives a clear view of how the top line has held up as earnings have come under pressure. For...

With no single headline event driving attention today, Hochiki (TSE:6745) is drawing interest based on its recent share price performance and fundamentals, including ¥104,440 in revenue and ¥8,423 in net income. See our latest analysis for Hochiki. At a share price of ¥6,450, Hochiki’s 90 day share price return of 45.60% contrasts with a very large 5 year total shareholder return of 417.97%. This suggests that momentum has been building over time as investors reassess the company’s risk and...

Soundwill Holdings (SEHK:878) has reported FY 2025 first half revenue of HK$180.7 million and a basic EPS loss of HK$4.72 per share, with trailing twelve month figures showing revenue of HK$358.2 million and a net income loss of HK$2.1 billion. Over the past few reporting halves, the company has seen revenue move from HK$1,030.1 million in 1H 2024 to HK$199.6 million in 2H 2024 and HK$180.7 million in 1H 2025, while basic EPS shifted from a loss of HK$3.44 to HK$5.35 and then HK$4.72. For...

Tysan Holdings (SEHK:687) has just reported its FY 2025 first half numbers, with revenue of HK$1.2b and basic EPS of HK$0.010142, setting the tone for how the year is shaping up. The company has seen revenue move from HK$1,009.4m in 1H FY 2024 to HK$1,150.3m in 1H FY 2025, while basic EPS has gone from HK$0.00318 to HK$0.010142 over the same stretch, giving a clear view of how the top and bottom lines are tracking year on year. With trailing 12 month net margin at 3%, the latest results...

CVR Energy overview and recent share performance CVR Energy (CVI) has drawn fresh attention after a sharp recent move in its share price, with the stock closing at $33.82 and posting notable returns over the past month and past 3 months. See our latest analysis for CVR Energy. The recent 51.25% 1 month share price return, on top of a 34.26% year to date share price return and a 59.53% 1 year total shareholder return, points to building momentum as investors reassess CVR Energy's risk and...

Cross-Harbour (Holdings) (SEHK:32) has reported FY 2025 first half revenue of HK$825.3 million, with basic EPS of HK$1.34 and trailing twelve month EPS of HK$1.89, set against reported earnings growth of 63.5% over the past year. The company has seen revenue move from HK$586.99 million in 1H 2024 to HK$638.34 million in 2H 2024 and then to HK$825.3 million in 1H 2025. Trailing twelve month net income excluding extra items has reached HK$704.84 million, giving investors a results set framed by...

In March 2026, Walgreens announced a nationwide initiative with Exact Sciences and Workflow Services that lets eligible, average-risk customers request the FDA-approved, at-home Cologuard colorectal cancer screening test through its pharmacies, aiming to close care gaps with pharmacist-led services integrated into store workflows. At the same time, Exact Sciences highlighted new data on its Oncodetect molecular residual disease test and Cancerguard multi-cancer early detection assay at the...

If you are wondering whether HealthEquity is attractively priced or if the opportunity has already passed, this article walks through the key numbers that matter for valuation. The stock last closed at US$81.02, with returns of 4.1% over 7 days and 5.1% over 30 days. Year to date the return stands at an 11.0% decline and the 1-year return is a 4.5% decline, compared with a 44.6% gain over 3 years and 15.7% over 5 years. Recent headlines around HealthEquity have focused on its position in...

AGNC Investment (AGNC) has put dividends back in the spotlight after its Board declared a US$0.12 common stock dividend for March 2026, alongside fresh quarterly dividends across multiple preferred series. See our latest analysis for AGNC Investment. Despite the fresh dividend announcements, AGNC’s share price has been under pressure in the short term, with a 1‑month share price return of a 13.79% decline and a year-to-date share price return of a 10.80% decline. Its 1‑year and 3‑year total...

Earlier in March 2026, options traders showed unusually strong interest in Mobileye Global (NASDAQ: MBLY) calls ahead of its upcoming earnings, while Mobileye and Elektrobit announced a collaboration to integrate EB corbos Linux for Safety Applications into the Mobileye Drive Level 4 autonomous driving platform. This combination of options positioning and a safety-focused software partnership highlights how capital markets and technology ecosystems are converging around Mobileye’s autonomous...

Z Fin (SEHK:1168) has put out a mixed FY 2025 print, with first half revenue of HK$280.3 million and a basic EPS loss of HK$1.59, against a trailing 12 month picture that shows HK$566.0 million of revenue and a basic EPS loss of HK$2.97. Over recent periods the company has seen revenue move from HK$103.4 million in the first half of FY 2024 to HK$172.4 million in the second half and then to HK$280.3 million in the first half of FY 2025, while basic EPS has swung between a loss of HK$0.47, a...

Tai Hing Group Holdings (SEHK:6811) has just wrapped up FY 2025 with first half revenue of HK$1,712.2 million and basic EPS of HK$0.0419, setting the tone for how the rest of the year could shape investor expectations. The company has seen revenue progress from HK$1,612.5 million in 1H 2024 to HK$1,679.5 million in 2H 2024 and HK$1,712.2 million in 1H 2025, while basic EPS moved from HK$0.0107 to HK$0.0518 and then HK$0.0419 over the same periods. With net profit margin higher over the last...

C C Land Holdings (SEHK:1224) has reported its FY 2025 first half results with revenue of HK$250.3 million and a basic EPS loss of HK$0.0095, while trailing twelve month figures show revenue of HK$546.3 million and a basic EPS loss of HK$0.1202 as the company remains unprofitable. Over the past three reported halves, revenue has moved from HK$244.1 million in 1H FY 2024 to HK$264.2 million in 2H FY 2024 and then HK$250.3 million in 1H FY 2025. EPS shifted from a profit of HK$0.0234 in 1H FY...

Investors may be wondering if Home Depot at around US$320 a share still stacks up as good value, or if most of the upside has already been priced in. The stock is down 5.4% over the past week, 16.4% over the last month, and 7.2% year to date, while the 1 year return sits at a 6.3% loss and the 3 and 5 year returns are 22.2% and 19.3% respectively. Taken together, this provides a mixed picture of recent sentiment versus longer term performance. Recent headlines have focused on broader...

In March 2026, Kohl's reported fourth-quarter revenue of US$5,173 million and net income of US$125 million, alongside full-year revenue of US$15,527 million and net income of US$272 million, while guiding full-year 2026 net and comparable sales to range from a 2% decline to flat. Under new CEO Michael Bender, Kohl's halted further store closures, with about 1,150 locations and over 90% of stores profitable, signaling a shift toward improving performance at existing stores rather than...

Shanghai Haohai Biological Technology (SEHK:6826) has wrapped up FY 2025 with fourth quarter revenue of C¥573.9 million and a basic EPS loss of C¥0.23, while the trailing twelve month basic EPS sits at C¥1.08 on revenue of about C¥2.5 billion. Over recent periods the company has seen quarterly revenue move between C¥573.9 million and C¥685.9 million, with basic EPS ranging from a loss of C¥0.23 to a profit of C¥0.52. This presents a mixed earnings picture across the year. With a trailing net...

Taysha Gene Therapies (NasdaqGS:TSHA) received FDA Breakthrough Therapy designation for TSHA-102 in Rett syndrome. The company reported a 100% patient response rate in pivotal Phase I/II data for TSHA-102. Regulators aligned with Taysha on pivotal trial designs for its lead Rett syndrome program. Taysha added a key commercial hire as it prepares for potential TSHA-102 commercialization. Taysha Gene Therapies, trading at $4.4 per share, has been drawing attention as its 1 year return stands...

Earlier in March 2026, Hormel Foods used Pizza Expo to showcase new offerings like Hot Calabrian Chili Sausage while outlining five emerging pizza trends centered on specialized heat, premium proteins, global fusion flavors, and crust innovation. By leaning into highly specific flavors such as Calabrian chili and protein-heavy "Triple Pepperoni" pies, Hormel is positioning its HORMEL and FONTANINI brands to capture evolving restaurant menus and consumer demand for more adventurous, artisanal...

Sterling Infrastructure (STRL) has drawn investor attention after recent trading, with the stock closing at $401.61. The move comes against a backdrop of mixed short term returns and strong multi year total returns. See our latest analysis for Sterling Infrastructure. The recent 1 day share price decline of 6.99% to US$401.61 comes after a 90 day share price return of 30.15% and a very large 5 year total shareholder return. This suggests that momentum has cooled in the short term, while...

For investors considering whether Verisk Analytics at around US$201.75 represents fair value or a potential opportunity, this article focuses on what the current price might imply. The stock recently posted a 0.3% return over 7 days and 9.6% over 30 days, while the year-to-date return is an 8.7% decline and the 1-year return is a 28.7% decline. Recent headlines have highlighted Verisk Analytics as a data and analytics provider in the commercial services space, with attention on how its core...

China Traditional Chinese Medicine Holdings (SEHK:570) has reported its FY 2025 first half results with revenue of C¥7.5b and a basic EPS loss of C¥0.02, while the trailing twelve months show revenue of C¥14.7b and a basic EPS loss of C¥0.07. Over recent half year periods, revenue has moved from C¥8.4b with EPS of C¥0.04 in 1H 2024 to C¥8.1b with an EPS loss of C¥0.03 in 2H 2024, then to C¥7.5b with an EPS loss of C¥0.02 in 1H 2025, setting up a story where investors are weighing weaker...

China Power International Development (SEHK:2380) has released its FY 2025 results with first half revenue of C¥24.7b and basic EPS of C¥0.21, while trailing twelve month revenue sits at C¥53.0b with EPS of C¥0.24. Over recent periods, the company has seen revenue move from C¥27.2b in 1H 2024 to C¥29.1b in 2H 2024 and then C¥24.7b in 1H 2025, alongside basic EPS figures of C¥0.21, C¥0.06 and C¥0.21 respectively. This sets up a picture where modest earnings growth and slightly stronger net...

Onewo (SEHK:2602) has reported its FY 2025 first half results with revenue of C¥18.1b and basic EPS of C¥0.68, setting the tone for how the rest of the year could shape expectations around earnings quality. Over the last three reported half year periods, revenue has moved from C¥17.6b in 1H 2024 to C¥18.7b in 2H 2024 and C¥18.1b in 1H 2025, while basic EPS printed at C¥0.65, C¥0.32 and C¥0.68 across those same periods. This gives investors a clear view of how the top line and per share profit...